The Valley Desk

ArticlePLoS pathogensPublished

Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization

23 of 33 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
PLoS pathogens
Published
Subject terms
Animals; Humans; Mice; Antibodies, Viral; Epitopes; Cross Reactions; Binding Sites; Female; Nanoparticles; Antibodies, Neutralizing; Spike Glycoprotein, Coronavirus; COVID-19
PubMed ID
41712614
PubMed Central ID
PMC13120701
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal